Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment

被引:0
|
作者
Hooning, M. [1 ]
Jager, A. [1 ]
Koppert, L. [2 ]
Van Deurzen, C. [3 ]
Collee, M. [4 ]
Hollestelle, A. [1 ]
Seynaeve, C. [1 ]
机构
[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands
[2] Erasmus MC Canc Inst, Surg Oncol, Rotterdam, Netherlands
[3] Erasmus MC Canc Inst, Pathol, Rotterdam, Netherlands
[4] Erasmus MC Canc Inst, Clin Genet, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
483
引用
收藏
页码:S140 / S140
页数:1
相关论文
共 50 条
  • [21] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Timothy R Rebbeck
    Susan M Domchek
    [J]. Breast Cancer Research, 10
  • [22] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Rebbeck, Timothy R.
    Domchek, Susan M.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (04)
  • [23] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Salmena, Leonardo
    Lynch, Henry T.
    Kim-Sing, Charmaine
    Foulkes, William D.
    Ghadirian, Parviz
    Neuhausen, Susan L.
    Demsky, Rochelle
    Tung, Nadine
    Ainsworth, Peter
    Senter, Leigha
    Eisen, Andrea
    Eng, Charis
    Singer, Christian
    Ginsburg, Ophira
    Blum, Joanne
    Huzarski, Tomasz
    Poll, Aletta
    Sun, Ping
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH, 2012, 14 (02):
  • [24] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly
    Lynch, Henry T.
    Ghadirian, Parviz
    Tung, Nadine
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Domchek, Susan
    Eisen, Andrea
    Foulkes, William D.
    Rosen, Barry
    Vesprini, Danny
    Sun, Ping
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 287 - 296
  • [25] IMPACT OF PREGNANCY ON THE RISK OF BREAST AND OVARIAN CANCER IN BRCA1 AND BRCA2 MUTATION CARRIERS
    Russo, M.
    Corvetto, E.
    Fais, M.
    Candotti, G.
    Locati, V.
    Proto, A.
    Angioni, S.
    Carcassi, C.
    Mais, V.
    Peiretti, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A391 - A391
  • [26] Contralateral Breast Cancer in BRCA1/BRCA2 Mutation Carriers: The Story of the Other Side
    Garber, Judy E.
    Golshan, Mehra
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5862 - 5864
  • [27] Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
    KA Phillips
    RL Milne
    MA Rookus
    D Goldgar
    M Friedlander
    SA McLachlan
    S Buys
    AC Antoniou
    K Birch
    MB Terry
    DF Easton
    P Weideman
    M Daly
    N Andrieu
    EM John
    MJ Hooning
    IL Andrulis
    T Caldes
    H Olsson
    JL Hopper
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [28] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    van Sprundel, TC
    Schmidt, MK
    Rookus, MA
    Brohet, R
    van Asperen, CJ
    Rutgers, EJT
    van't Veer, L
    Tollenaar, RAEM
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 287 - 292
  • [29] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    T C van Sprundel
    M K Schmidt
    M A Rookus
    R Brohet
    C J van Asperen
    E J Th Rutgers
    L J van‘t Veer
    R A E M Tollenaar
    [J]. British Journal of Cancer, 2005, 93 : 287 - 292
  • [30] Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers:: an update
    Gronwald, J
    Tung, N
    Foulkes, WD
    Offit, K
    Gershoni, R
    Daly, M
    Kim-Sing, C
    Olsson, H
    Ainsworth, P
    Eisen, A
    Saal, H
    Friedman, E
    Olopade, O
    Osborne, M
    Weitzel, J
    Lynch, H
    Ghadirian, P
    Lubinski, J
    Sun, P
    Narod, SA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (09) : 2281 - 2284